Keep Different Weight Loss Meds Straight During Transitions of Care

Please see the February 2020 FDA recommendation to remove Belviq and Belviq XR from the market.

New versions of phentermine (Lomaira, loh-MER-uh) and lorcaserin (Belviq XR) will add to the plethora of weight loss meds.

Over one in three Americans are obese...and many are turning to medications to help lose weight.

Develop transitions-of-care plans for these meds.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote